According to a new study in Germany, biopsies taken to diagnose prostate cancer commonly cause temporary erectile dysfunction and, in some cases, lingering urinary problems. And men who are undergoing prostate biopsies — as well as those considering prostate cancer screening — should be aware of those risks. Experts say.this is especially important for men […]

continue reading from " Prostate biopsy can cause erectile and urinary problems "

Experts agree male sexual arousal is complex. It involves many facts such as the senses, emotions, the brain, hormones, nerves, muscles and blood vessels. Even so, most men should be able to enjoy sex to a ripe old age.
Erectile dysfunction (ED) is the medical term for popular impotence. It defines the condition when a man […]

continue reading from " Treating erectile dysfunction "

A new study at the University of Florence, Italy, found that the presence of depressive symptoms in men with erectile dysfunction constitutes a risk factor for a major cardiovascular event.
Erectile dysfunction and depression are often associated, and both are associated with an increased risk of cardiovascular disease and death. To investigate clinical correlates further, researchers […]

continue reading from " Depressive mood increases cardiovascular problems in men with erectile dysfunction "

The Committee on “Clinical Evaluation and Scales in Sexual Medicine” of the third International Consultation in Sexual Medicine aimed to provide an overview of current practice and new developments in the field of diagnostic testing in male erectile dysfunction (ED).
They reviewed current practice and new developments in the field of physiological testing in male ED […]

continue reading from " Diagnostic tests for male erectile dysfunction revisited "

According to new data presented today at the World Congress of Cardiology (WCC) Scientific Sessions in Beijing, China, seven out of 10 men admitted to hospital for a heart attack (acute ST segment elevation myocardial infarction (STEMI)) had erectile dysfunction (ED) in the six months prior to their admission.
The study developed by a team at […]

continue reading from " Most men with erectile dysfunction at high risk of heart attack "

VIVUS, Inc. recently announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction in men with type 1 and type 2 diabetes.
The above mentioned study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement […]

continue reading from " Positive results of avanafil for ED in men with diabetes "

A study at Department of the Medical School, São José do Rio Preto, Brazil. investigated the effect of systemic arterial pressure on erectile dysfunction (ED) in patients in the initial stages of peripheral arterial disease.
Reseachers concluded the progression of erectile dysfunction parallels the development of chronic arterial insufficiency. Systemic arterial hypertension in the initial stages […]

continue reading from " Influence of systemic arterial pressure on erectile dysfunction "

A new study at the University of Alabama at Birmingham suggests the erectile dysfunction drug Viagra, and possibly other similar medications, may prompt long-term hearing loss among users,
In the May 18 issue of the Archives of Otolaryngology — Head and Neck Surgery, researchers discuss evidence supporting an association between the onset of hearing problems and […]

continue reading from " Viagra linked to hearing loss "

A paper published in the June issue of IJCP, the International Journal of Clinical Practice, shows that men with erectile dysfunction (ED) will often develop coronary symptoms within two to three years of impotence and actually experience a cardiovascular event, such as a heart attack, within three to five years.
The authors stress that it is […]

continue reading from " Significant part of men with erectile dysfunction exhibit early signs of coronary artery disease "

New research conducted at Cedars-Sinai’s Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors. The scientific team found that the erectile dysfunction drugs sildenafil (Viagra) and vardenafil (Levitra), which inhibit the enzyme phosphodiesterase 5 (PDE5), […]

continue reading from " Erectile dysfuncton drug may enhance delivery of herceptin to certain brain tumors "